Global Transdermal Drug Patches Market Insights and Forecast to 2028
The global Transdermal Drug Patches market size was value at US$ 6,680.25 million in 2021 and is forecast to be a readjusted size of US$ 7630.01 million by 2028 with a CAGR of 1.86% during the forecast period 2022-2028.
Akshay Sawarkar
The global Transdermal Drug Patches market size was value at US$ 6,680.25 million in 2021 and is forecast to be a readjusted size of US$ 7630.01 million by 2028 with a CAGR of 1.86% during the forecast period 2022-2028.
The global main manufacturers of Transdermal Drug Patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, and IBSA Group, etc. In 2021, the global six largest players have a share approximately 41.80% in terms of revenue.
Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6951873/global-transdermal-drug-patches-2028-136
The North America Transdermal Drug Patches market size was US$ 3,340.28 million in 2021, while China was about US$ 288.23 million. The proportion of the China was 4.31% in 2021 and it is predicted that the share will reach 8.89% in 2028, trailing a CAGR of 12.34% through the analysis period.
Fully considering the economic change by the COVID-19, Methyl Salicylate-based Patch accounting for 13.17% of the Transdermal Drug Patches global market in 2021, is projected to value US$ 800.46 million by 2028, growing at a revised -0.91% CAGR from 2022 to 2028. While Rx Channel segment is altered to an 1.77% CAGR throughout this forecast period and will hold a share about 93.49% in 2028.
Transdermal Drug Patches market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Methyl Salicylate-based Patch
- Rivastigmine Transdermal Patch
- Fentanyl Transdermal Patch
- Lidocaine Patch
- Diclofenac Patch
- Nicotine Transdermal Patch
- Others
Segment by Application
- Rx Channel
- OTC Channel
By Company
- Hisamitsu Pharmaceutical
- Johnson & Johnson
- Mylan
- UCB Pharma
- Novartis
- Teva Pharmaceutical
- Beijing Tide Pharmaceutical
- Chattem
- Nitto Denko
- Grünenthal
- Mundipharma
- GSK
- Luye Pharma Group
- Bayer
- IBSA Group
- Dr Reddy’s Laboratories
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Get the Complete Report & TOC @ https://www.statsmarketresearch.com/global-transdermal-drug-patches-2028-136-6951873
Table of content
1 Study Coverage1.1 Transdermal Drug Patches Product Introduction1.2 Market by Type1.2.1 Global Transdermal Drug Patches Market Size Growth Rate by Type, 2017 VS 2021 VS 20281.2.2 Methyl Salicylate-based Patch1.2.3 Rivastigmine Transdermal Patch1.2.4 Fentanyl Transdermal Patch1.2.5 Lidocaine Patch1.2.6 Diclofenac Patch1.2.7 Nicotine Transdermal Patch1.2.8 Others1.3 Market by Application1.3.1 Global Transdermal Drug Patches Market Size Growth Rate by Application, 2017 VS 2021 VS 20281.3.2 Rx Channel1.3.3 OTC Channel1.4 Study Objectives1.5 Years Considered2 Executive Summary2.1 Global Transdermal Drug Patches Sales Estimates and Forecasts 2017-20282.2 Global Transdermal Drug Patches Revenue Estimates and Forecasts 2017-20282.3 Global Transdermal Drug Patches Revenue by Region: 2017 VS 2021 VS 20282.4 Global Transdermal Drug Patches Sales by Region2.4.1 Global Transdermal Drug Patches Sales by Region (2017-2022)2.4.2 Global Sales Transdermal Drug Patches by Region (2023-2028)2.5 Global Transdermal Drug Patches Revenue by Region2.5.1 Global Transdermal Drug Patches Revenue by Region (2017-2022)2.5.2 Global Transdermal Drug Patches Revenue by Region (2023-2028)2.6 North America2.7 Europe2.8 Asia-Pacific2.9 Latin America
Customize/Section/Part Purchase @ https://www.statsmarketresearch.com/chapters-purchase/6951873/global-transdermal-drug-patches-2028-136
CONTACT US:276 5th Avenue, New York, NY 10001, United StatesInternational: +1(646)-781-7170 / +91 8087042414Similar Reports:2022-2027 Global and Regional Transdermal Drug Patches Industry Status and Prospects Professional Market Research Report Standard Version2022-2027 Global and Regional Transdermal Drug Patches Industry Status and Prospects Professional Market Research Report Standard VersionGlobal Transdermal Drug Delivery Patches Market Insights, Forecast to 2028Transdermal Drug Delivery Patches Market, Global Outlook and Forecast 2022-2028
Upvote
Akshay Sawarkar

Related Articles